Pracinostat

Pracinostat (SB939) is an orally bioavailable HDAC inhibitor with potent anti-tumor activity. It demonstrates efficacy in preclinical models of hematological malignancies and solid tumors, supporting its research use in oncology and epigenetics.

Product Specifications

CAS Number

929016-96-6

Product Name Alternative

SB 939, SB939, SB-939, Pracinostat, Histone deacetylases, HDAC8, HDAC9, HDAC1, HDAC, HDAC2, HDAC3, HDAC10, HDAC11, HDAC7, HDAC6, HDAC5, HDAC4, MBLAC2, inhibit, Inhibitor, cancer, Apoptosis

Field of Research

Cell Biology, Epigenetics & Chromatin, Infectious Disease & Virology, Molecular Biology

Purity

99.15% (May vary between batches)

Solubility

DMSO:75 mg/mL (209.22 mM) ; Ethanol:26 mg/mL (72.53 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.58 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)